INDP
Indaptus Therapeutics Inc
NASDAQ: INDP · HEALTHCARE · BIOTECHNOLOGY
$2.80
-4.11% today
Updated 2026-04-30
Market cap
$7.69M
P/E ratio
—
P/S ratio
—
EPS (TTM)
$-21.58
Dividend yield
—
52W range
$2 – $20
Volume
0.1M
WallStSmart proprietary scores
21
out of 100
Grade: F
Strong Sell
Investment rating
4.3
Growth
C5.0
Quality
C+3.0
Profitability
D5.0
Valuation
C+—/9
Piotroski F-Score
—
—
Altman Z-Score
—
—
Industry rank
—
View all highly rated stocks (75+) →201 stocks currently score above 75
Price targets
Analyst target
$10.00
+257.14%
12-Month target
—
—
Intrinsic (DCF)
—
Margin of safety
—
Price chart
X-Ray snapshot
Strengths
Insufficient data
Risks
- Thin margins at 0.00%
- Negative free cash flow $-3.19M
Key financials
Revenue Net Income Free Cash Flow
| Metric | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|
| Revenue | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Net income | $-14.32M | $-15.42M | $-15.02M | $-20.85M | $-8.11M |
| EPS | — | — | — | — | $-21.58 |
| Free cash flow | $-13.25M | $-13.41M | $-12.32M | $-14.82M | $-3.19M |
| Profit margin | — | — | — | — | — |
Peer comparison
Smart narrative
Indaptus Therapeutics Inc trades at $2.80. Our Smart Value Score of 21/100 indicates the stock is weak.
Frequently asked questions
What is Indaptus Therapeutics Inc's stock price?
Indaptus Therapeutics Inc (INDP) trades at $2.80.
Is Indaptus Therapeutics Inc overvalued?
Smart Value Score 21/100 (Grade F, Strong Sell).
What is the price target of Indaptus Therapeutics Inc (INDP)?
The analyst target price is $10.00, representing +257.1% upside from the current price of $2.80.
Company info
SectorHEALTHCARE
IndustryBIOTECHNOLOGY
CountryUSA
ExchangeNASDAQ
CurrencyUSD
Quick metrics
P/S ratio—
ROE-588.00%
Beta0.99
50D MA$2.12
200D MA$3.70
Shares out0.00B
Float0.00B
Short ratio—
Avg volume0.1M
Performance
1 week—
1 month—
3 months—
YTD—
1 year—
3 years—
5 years—